PASG FY 2023 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$29M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4M

Operating Income

-$100M

Net Income

-$102M

EPS (Diluted)

$-37.29

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$78M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$151M

Total Liabilities

$39M

Stockholders' Equity

$111M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4M	$0	—
Operating Income	-$100M	-$138M	+27.6%
Net Income	-$102M	-$136M	+25.0%